Report Cover

Global Pet Biopharmaceuticals Market Growth (Status and Outlook) 2021-2026


According to this latest study, the 2021 growth of Pet Biopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Pet Biopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pet Biopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Antiparasitic
    Biological Products
    Antibacterial
    Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Prevention
    Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Pet Biopharmaceuticals Market Size 2016-2026
        2.1.2 Pet Biopharmaceuticals Market Size CAGR by Region 2020 VS 2021 VS 2026
    2.2 Pet Biopharmaceuticals Segment by Type
        2.2.1 Antiparasitic
        2.2.2 Antiparasitic
        2.2.3 Antibacterial
        2.2.4 Others
    2.3 Pet Biopharmaceuticals Market Size by Type
        2.3.1 Global Pet Biopharmaceuticals Market Size CAGR by Type
        2.3.2 Global Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021)
    2.4 Pet Biopharmaceuticals Segment by Application
        2.4.1 Prevention
        2.4.2 Treatment
    2.5 Pet Biopharmaceuticals Market Size by Application
        2.5.1 Global Pet Biopharmaceuticals Market Size CAGR by Application
        2.5.2 Global Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021)

3 Pet Biopharmaceuticals Market Size by Players
    3.1 Pet Biopharmaceuticals Market Size Market Share by Players
        3.1.1 Global Pet Biopharmaceuticals Revenue by Players (2019-2021E)
        3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2019-2021E)
    3.2 Global Pet Biopharmaceuticals Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Pet Biopharmaceuticals by Regions
    4.1 Pet Biopharmaceuticals Market Size by Regions (2016-2021)
    4.2 Americas Pet Biopharmaceuticals Market Size Growth (2016-2021)
    4.3 APAC Pet Biopharmaceuticals Market Size Growth (2016-2021)
    4.4 Europe Pet Biopharmaceuticals Market Size Growth (2016-2021)
    4.5 Middle East & Africa Pet Biopharmaceuticals Market Size Growth (2016-2021)

5 Americas
    5.1 Americas Pet Biopharmaceuticals Market Size by Country (2016-2021)
    5.2 Americas Pet Biopharmaceuticals Market Size by Type (2016-2021)
    5.3 Americas Pet Biopharmaceuticals Market Size by Application (2016-2021)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Pet Biopharmaceuticals Market Size by Region (2016-2021)
    6.2 APAC Pet Biopharmaceuticals Market Size by Type (2016-2021)
    6.3 APAC Pet Biopharmaceuticals Market Size by Application (2016-2021)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Pet Biopharmaceuticals by Country (2016-2021)
    7.2 Europe Pet Biopharmaceuticals Market Size by Type (2016-2021)
    7.3 Europe Pet Biopharmaceuticals Market Size by Application (2016-2021)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Pet Biopharmaceuticals by Region (2016-2021)
    8.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2016-2021)
    8.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2016-2021)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Pet Biopharmaceuticals Market Forecast
    10.1 Global Pet Biopharmaceuticals Forecast by Regions (2021-2026)
        10.1.1 Global Pet Biopharmaceuticals Forecast by Regions (2021-2026)
        10.1.2 Americas Pet Biopharmaceuticals Forecast
        10.1.3 APAC Pet Biopharmaceuticals Forecast
        10.1.4 Europe Pet Biopharmaceuticals Forecast
        10.1.5 Middle East & Africa Pet Biopharmaceuticals Forecast
    10.2 Americas Pet Biopharmaceuticals Forecast by Countries (2021-2026)
        10.2.1 United States Pet Biopharmaceuticals Market Forecast
        10.2.2 Canada Pet Biopharmaceuticals Market Forecast
        10.2.3 Mexico Pet Biopharmaceuticals Market Forecast
        10.2.4 Brazil Pet Biopharmaceuticals Market Forecast
    10.3 APAC Pet Biopharmaceuticals Forecast by Region (2021-2026)
        10.3.1 China Pet Biopharmaceuticals Market Forecast
        10.3.2 Japan Pet Biopharmaceuticals Market Forecast
        10.3.3 Korea Pet Biopharmaceuticals Market Forecast
        10.3.4 Southeast Asia Pet Biopharmaceuticals Market Forecast
        10.3.5 India Pet Biopharmaceuticals Market Forecast
        10.3.6 Australia Pet Biopharmaceuticals Market Forecast
    10.4 Europe Pet Biopharmaceuticals Forecast by Country (2021-2026)
        10.4.1 Germany Pet Biopharmaceuticals Market Forecast
        10.4.2 France Pet Biopharmaceuticals Market Forecast
        10.4.3 UK Pet Biopharmaceuticals Market Forecast
        10.4.4 Italy Pet Biopharmaceuticals Market Forecast
        10.4.5 Russia Pet Biopharmaceuticals Market Forecast
    10.5 Middle East & Africa Pet Biopharmaceuticals Forecast by Region (2021-2026)
        10.5.1 Egypt Pet Biopharmaceuticals Market Forecast
        10.5.2 South Africa Pet Biopharmaceuticals Market Forecast
        10.5.3 Israel Pet Biopharmaceuticals Market Forecast
        10.5.4 Turkey Pet Biopharmaceuticals Market Forecast
        10.5.5 GCC Countries Pet Biopharmaceuticals Market Forecast
    10.6 Global Pet Biopharmaceuticals Forecast by Type (2021-2026)
    10.7 Global Pet Biopharmaceuticals Forecast by Application (2021-2026)

11 Key Players Analysis
    11.1 Zoetis
        11.1.1 Zoetis Company Information
        11.1.2 Zoetis Pet Biopharmaceuticals Product Offered
        11.1.3 Zoetis Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.1.4 Zoetis Main Business Overview
        11.1.5 Zoetis Latest Developments
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Information
        11.2.2 Boehringer Ingelheim Pet Biopharmaceuticals Product Offered
        11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.2.4 Boehringer Ingelheim Main Business Overview
        11.2.5 Boehringer Ingelheim Latest Developments
    11.3 Merck
        11.3.1 Merck Company Information
        11.3.2 Merck Pet Biopharmaceuticals Product Offered
        11.3.3 Merck Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.3.4 Merck Main Business Overview
        11.3.5 Merck Latest Developments
    11.4 Elanco
        11.4.1 Elanco Company Information
        11.4.2 Elanco Pet Biopharmaceuticals Product Offered
        11.4.3 Elanco Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.4.4 Elanco Main Business Overview
        11.4.5 Elanco Latest Developments
    11.5 Virbac
        11.5.1 Virbac Company Information
        11.5.2 Virbac Pet Biopharmaceuticals Product Offered
        11.5.3 Virbac Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.5.4 Virbac Main Business Overview
        11.5.5 Virbac Latest Developments
    11.6 Dechra Veterinary Products
        11.6.1 Dechra Veterinary Products Company Information
        11.6.2 Dechra Veterinary Products Pet Biopharmaceuticals Product Offered
        11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.6.4 Dechra Veterinary Products Main Business Overview
        11.6.5 Dechra Veterinary Products Latest Developments
    11.7 Ceva
        11.7.1 Ceva Company Information
        11.7.2 Ceva Pet Biopharmaceuticals Product Offered
        11.7.3 Ceva Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.7.4 Ceva Main Business Overview
        11.7.5 Ceva Latest Developments
    11.8 Vetoquinol
        11.8.1 Vetoquinol Company Information
        11.8.2 Vetoquinol Pet Biopharmaceuticals Product Offered
        11.8.3 Vetoquinol Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.8.4 Vetoquinol Main Business Overview
        11.8.5 Vetoquinol Latest Developments
    11.9 Ouro Fino Saude
        11.9.1 Ouro Fino Saude Company Information
        11.9.2 Ouro Fino Saude Pet Biopharmaceuticals Product Offered
        11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.9.4 Ouro Fino Saude Main Business Overview
        11.9.5 Ouro Fino Saude Latest Developments
    11.10 Norbrook
        11.10.1 Norbrook Company Information
        11.10.2 Norbrook Pet Biopharmaceuticals Product Offered
        11.10.3 Norbrook Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.10.4 Norbrook Main Business Overview
        11.10.5 Norbrook Latest Developments
    11. Jindun
        11.11.1 Jindun Company Information
        11.11.2 Jindun Pet Biopharmaceuticals Product Offered
        11.11.3 Jindun Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.11.4 Jindun Main Business Overview
        11.11.5 Jindun Latest Developments
    11.12 Chopperlvya Animal Health
        11.12.1 Chopperlvya Animal Health Company Information
        11.12.2 Chopperlvya Animal Health Pet Biopharmaceuticals Product Offered
        11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.12.4 Chopperlvya Animal Health Main Business Overview
        11.12.5 Chopperlvya Animal Health Latest Developments
    11.13 CAHIC
        11.13.1 CAHIC Company Information
        11.13.2 CAHIC Pet Biopharmaceuticals Product Offered
        11.13.3 CAHIC Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
        11.13.4 CAHIC Main Business Overview
        11.13.5 CAHIC Latest Developments

12 Research Findings and Conclusion

List of Tables Table 1. Pet Biopharmaceuticals Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Antiparasitic Table 3. Major Players of Biological Products Table 4. Major Players of Antibacterial Table 5. Major Players of Others Table 6. Pet Biopharmaceuticals Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global Pet Biopharmaceuticals Market Size by Type (2016-2021) & ($ Millions) Table 8. Global Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021) Table 9. Pet Biopharmaceuticals Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global Pet Biopharmaceuticals Market Size by Application (2016-2021) & ($ Millions) Table 11. Global Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021) Table 12. Global Pet Biopharmaceuticals Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global Pet Biopharmaceuticals Revenue Market Share by Players (2019-2021E) Table 14. Pet Biopharmaceuticals Key Players Head office and Products Offered Table 15. Pet Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Pet Biopharmaceuticals Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global Pet Biopharmaceuticals Market Size Market Share by Regions 2016-2021 Table 20. Americas Pet Biopharmaceuticals Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas Pet Biopharmaceuticals Market Size Market Share by Country (2016-2021) Table 22. Americas Pet Biopharmaceuticals Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021) Table 24. Americas Pet Biopharmaceuticals Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021) Table 26. APAC Pet Biopharmaceuticals Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC Pet Biopharmaceuticals Market Size Market Share by Region (2016-2021) Table 28. APAC Pet Biopharmaceuticals Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021) Table 30. APAC Pet Biopharmaceuticals Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021) Table 32. Europe Pet Biopharmaceuticals Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe Pet Biopharmaceuticals Market Size Market Share by Country (2016-2021) Table 34. Europe Pet Biopharmaceuticals Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021) Table 36. Europe Pet Biopharmaceuticals Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa Pet Biopharmaceuticals Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of Pet Biopharmaceuticals Table 45. Key Application and Potential Industries of Pet Biopharmaceuticals Table 46. Key Challenges of Pet Biopharmaceuticals Table 47. Key Trends of Pet Biopharmaceuticals Table 48. Global Pet Biopharmaceuticals Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global Pet Biopharmaceuticals Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Type (2021-2026) Table 52. Global Pet Biopharmaceuticals Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global Pet Biopharmaceuticals Market Size Market Share Forecast by Application (2021-2026) Table 54. Zoetis Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 55. Zoetis Pet Biopharmaceuticals Product Offered Table 56. Zoetis Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Zoetis Main Business Table 58. Zoetis Latest Developments Table 59. Boehringer Ingelheim Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 60. Boehringer Ingelheim Pet Biopharmaceuticals Product Offered Table 61. Boehringer Ingelheim Main Business Table 62. Boehringer Ingelheim Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Boehringer Ingelheim Latest Developments Table 64. Merck Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 65. Merck Pet Biopharmaceuticals Product Offered Table 66. Merck Main Business Table 67. Merck Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Merck Latest Developments Table 69. Elanco Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 70. Elanco Pet Biopharmaceuticals Product Offered Table 71. Elanco Main Business Table 72. Elanco Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Elanco Latest Developments Table 74. Virbac Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 75. Virbac Pet Biopharmaceuticals Product Offered Table 76. Virbac Main Business Table 77. Virbac Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. Virbac Latest Developments Table 79. Dechra Veterinary Products Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 80. Dechra Veterinary Products Pet Biopharmaceuticals Product Offered Table 81. Dechra Veterinary Products Main Business Table 82. Dechra Veterinary Products Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. Dechra Veterinary Products Latest Developments Table 84. Ceva Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 85. Ceva Pet Biopharmaceuticals Product Offered Table 86. Ceva Main Business Table 87. Ceva Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 88. Ceva Latest Developments Table 89. Vetoquinol Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 90. Vetoquinol Pet Biopharmaceuticals Product Offered Table 91. Vetoquinol Main Business Table 92. Vetoquinol Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 93. Vetoquinol Latest Developments Table 94. Ouro Fino Saude Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 95. Ouro Fino Saude Pet Biopharmaceuticals Product Offered Table 96. Ouro Fino Saude Main Business Table 97. Ouro Fino Saude Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 98. Ouro Fino Saude Latest Developments Table 99. Norbrook Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 100. Norbrook Pet Biopharmaceuticals Product Offered Table 101. Norbrook Main Business Table 102. Norbrook Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 103. Norbrook Latest Developments Table 104. Jindun Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 105. Jindun Pet Biopharmaceuticals Product Offered Table 106. Jindun Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 107. Jindun Main Business Table 108. Jindun Latest Developments Table 109. Chopperlvya Animal Health Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 110. Chopperlvya Animal Health Pet Biopharmaceuticals Product Offered Table 111. Chopperlvya Animal Health Main Business Table 112. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 113. Chopperlvya Animal Health Latest Developments Table 114. CAHIC Details, Company Type, Pet Biopharmaceuticals Area Served and Its Competitors Table 115. CAHIC Pet Biopharmaceuticals Product Offered Table 116. CAHIC Main Business Table 117. CAHIC Pet Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 118. CAHIC Latest Developments List of Figures Figure 1. Pet Biopharmaceuticals Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Pet Biopharmaceuticals Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Pet Biopharmaceuticals Market Size Market Share by Type in 2020 Figure 7. Pet Biopharmaceuticals in Prevention Figure 8. Global Pet Biopharmaceuticals Market: Prevention (2016-2021) & ($ Millions) Figure 9. Pet Biopharmaceuticals in Treatment Figure 10. Global Pet Biopharmaceuticals Market: Treatment (2016-2021) & ($ Millions) Figure 11. Global Pet Biopharmaceuticals Market Size Market Share by Application in 2020 Figure 12. Global Pet Biopharmaceuticals Revenue Market Share by Player in 2020 Figure 13. Global Pet Biopharmaceuticals Market Size Market Share by Regions (2016-2021) Figure 14. Americas Pet Biopharmaceuticals Market Size 2016-2021 ($ Millions) Figure 15. APAC Pet Biopharmaceuticals Market Size 2016-2021 ($ Millions) Figure 16. Europe Pet Biopharmaceuticals Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Pet Biopharmaceuticals Market Size 2016-2021 ($ Millions) Figure 18. Americas Pet Biopharmaceuticals Market Size Market Share by Country in 2020 Figure 19. Americas Pet Biopharmaceuticals Market Size Market Share by Type in 2020 Figure 20. Americas Pet Biopharmaceuticals Market Size Market Share by Application in 2020 Figure 21. United States Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Pet Biopharmaceuticals Market Size Market Share by Regions in 2020 Figure 25. APAC Pet Biopharmaceuticals Market Size Market Share by Type in 2020 Figure 26. APAC Pet Biopharmaceuticals Market Size Market Share by Application in 2020 Figure 27. China Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 31. India Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Pet Biopharmaceuticals Market Size Market Share by Country in 2020 Figure 34. Europe Pet Biopharmaceuticals Market Size Market Share by Type in 2020 Figure 35. Europe Pet Biopharmaceuticals Market Size Market Share by Application in 2020 Figure 36. Germany Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 37. France Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Pet Biopharmaceuticals Market Size Market Share by Application in 2020 Figure 44. Egypt Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Pet Biopharmaceuticals Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 50. APAC Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 51. Europe Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 53. United States Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 54. Canada Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 55. Mexico Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 56. Brazil Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 57. China Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 58. Japan Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 59. Korea Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 61. India Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 62. Australia Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 63. Germany Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 64. France Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 65. UK Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 66. Italy Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 67. Russia Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 68. Spain Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 69. Egypt Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 70. South Africa Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 71. Israel Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 72. Turkey Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Pet Biopharmaceuticals Market Size 2021-2026 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us